Readmission and Disposition in Patients With Malignant Bowel Obstructions Following Gastrostomy Tube

被引:0
作者
Yu, Jingjing [1 ]
Sullivan, Brittany G. [1 ]
Nguyen, Ninh T. [1 ]
Hohmann, Samuel F. [2 ]
Harris, Alyssa H. [2 ]
Micic, Dejan [3 ]
Turaga, Kiran K. [4 ]
Senthil, Maheswari [1 ]
Eng, Oliver S. [1 ,5 ]
机构
[1] Univ Calif Orange, Irvine Med Ctr, Dept Surg, Orange, CA USA
[2] Vizient Inc, Ctr Adv Analyt & Informat, Chicago, IL USA
[3] Univ Chicago, Dept Internal Med Sect Gastroenterol Hepatol & Nut, Chicago, IL USA
[4] Yale Univ, Dept Surg, New Haven, CT USA
[5] Univ Calif Orange, Irvine Dept Surg, 3800 Chapman Ave,Suite 6200, Orange, CA 92868 USA
关键词
peritoneal carcinomatosis; malignant bowel obstruction; gastrostomy tube; 30-day readmission; disposition; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; MANAGEMENT; DECOMPRESSION; PROGNOSIS; PROTOCOL;
D O I
10.1177/00031348231180915
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Patients with peritoneal carcinomatosis (PC) can develop malignant bowel obstructions (MBOs) requiring inpatient admission and nasogastric tube decompression. Palliative decompressive gastrostomy tubes (G-tubes) may affect patient disposition, allowing for self-management and reduction in inpatient services. Therefore, we sought to assess disposition and inpatient readmission rates in patients admitted with PC and MBO following G-tube placement.Methods: The Vizient (R) Clinical Data Base was queried for inpatient admissions from October 2018 to May 2022 utilizing ICD-10 codes to identify patients admitted with PC and bowel obstruction, with or without G-tube placement. Demographics and hospital outcomes were recorded. Descriptive statistics and multivariate logistic regression analysis were performed.Results: From 750 patients, 59 (7.9%) had a G-tube placed. Compared to patients without G-tubes, those with G-tubes had lower rates of disposition to home (32.2% vs 70.0%, P < .001) and higher rates of disposition to hospice (home: 30.5% vs 7.8%, P < .001, facility: 10.2% vs 3.9%, P = .02). There was no significant difference in the rate (17.3% vs 22.3%, P = .40) or risk (OR = 1.44, 95% CI .69-3.01) of 30-day readmissions with G-tubes. However, palliative care consultation (OR 33.77, 95% CI 19.16-59.52) and G-tube placement (OR 5.82, 95% CI 2.56-13.25) were independent predictors for hospice.Discussion: Placement of G-tubes in patients with PC and MBO was associated with higher rates of disposition to hospice but there is no difference in 30-day readmission rates compared to those without G-tubes. Further prospective studies are needed to understand the role of G-tube placement in patients with MBO in relation to outcomes and disposition.
引用
收藏
页码:5915 / 5920
页数:6
相关论文
共 17 条
  • [1] Report of the clinical protocol committee: Development of randomized trials for malignant bowel obstruction
    Anthony, Thomas
    Baron, Todd
    Mercadante, Sebastiano
    Green, Sylvan
    Chi, Dennis
    Cunningham, John
    Herbst, Anne
    Smart, Elizabeth
    Krouse, Robert S.
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2007, 34 (01) : S49 - S59
  • [2] Percutaneous venting gastrostomy/gastrojejunostomy for malignant bowel obstruction: a qualitative study
    Curry, Rebecca Singh
    Evans, Elizabeth
    Raftery, Anne-Marie
    Hiscock, Julia
    Poolman, Marlise
    [J]. BMJ SUPPORTIVE & PALLIATIVE CARE, 2019, 9 (04) : 381 - 388
  • [3] Management of Malignant Bowel Obstruction Associated With GI Cancers
    Franke, Aaron J.
    Iqbal, Atif
    Starr, Jason S.
    Nair, Rajesh M.
    George, Thomas J., Jr.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (07) : 426 - +
  • [4] A scoring system for the prognosis and treatment of malignant bowel obstruction
    Henry, Jon C.
    Pouly, Severin
    Sullivan, Rachael
    Sharif, Suhail
    Klemanski, Dori
    Abdel-Misih, Sherif
    Arradaza, Nicole
    Jaijoura, David
    Schmidt, Carl
    Bloomston, Mark
    [J]. SURGERY, 2012, 152 (04) : 747 - 757
  • [5] Percutaneous endoscopic gastrostomy for decompression of malignant bowel obstruction
    Kawata, Noboru
    Kakushima, Naomi
    Tanaka, Masaki
    Sawai, Hiroaki
    Imai, Kenichiro
    Hagiwara, Tomoko
    Takao, Toshitatsu
    Hotta, Kinichi
    Yamaguchi, Yuichiro
    Takizawa, Kohei
    Matsubayashi, Hiroyuki
    Ono, Hiroyuki
    [J]. DIGESTIVE ENDOSCOPY, 2014, 26 (02) : 208 - 213
  • [6] Protocol for the treatment of malignant inoperable bowel obstruction: A prospective study of 80 cases at Grenoble University Hospital Center
    Laval, G
    Arvieux, C
    Stefani, L
    Villard, ML
    Mestrallet, JP
    Cardin, N
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2006, 31 (06) : 502 - 512
  • [7] Recommendations for Bowel Obstruction With Peritoneal Carcinomatosis
    Laval, Guillemette
    Marcelin-Benazech, Blandine
    Guirimand, Frederic
    Chauvenet, Laure
    Copel, Laure
    Durand, Aurelie
    Francois, Eric
    Gabolde, Martine
    Mariani, Pascale
    Rebischung, Christine
    Servois, Vincent
    Terrebonne, Eric
    Arvieux, Catherine
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 48 (01) : 75 - 91
  • [8] Prognostic Factors for Surgical Failure in Malignant Bowel Obstruction and Peritoneal Carcinomatosis
    Lodoli, Claudio
    Covino, Marcello
    Attalla El Halabieh, Miriam
    Santullo, Francesco
    Di Giorgio, Andrea
    Abatini, Carlo
    Rotolo, Stefano
    Rodolfino, Elena
    Giovinazzo, Francesco
    Fagotti, Anna
    Scambia, Giovanni
    Franceschi, Francesco
    Pacelli, Fabio
    [J]. FRONTIERS IN SURGERY, 2021, 8
  • [9] McCorkle R, 1978, Cancer Nurs, V1, P373
  • [10] Drainage Percutaneous Endoscopic Gastrostomy for Malignant Bowel Obstruction in Gastrointestinal Cancers: Prognosis and Implications for Timing of Palliative Intervention
    Pinard, Kerry-Ann
    Goring, Tabitha N.
    Egan, Barbara C.
    Koo, Douglas J.
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2017, 20 (07) : 774 - 778